Morphosys Ag
Officers & Directors
1. Below are the executive and director profiles of MorphoSys AG that were available in my data.
MorphoSys AG Executives:
1. Jean-Paul Kress: CEO
Jean-Paul Kress is the CEO of MorphoSys AG since . Prior to joining MorphoSys, he was the CEO of Gensight Biologics, a biopharmaceutical company. He has also held executive positions in several global pharmaceutical companies, including Sanofi, Aventis, and Pfizer.
2. Jens Holstein: CFO
Jens Holstein is the CFO of MorphoSys AG since . Before joining MorphoSys, he had been the CFO for several pharmaceutical companies such as Wacker Chemical Corporation, KWS Saat and Strengmann Group.
3. Malte Peters: COO
Malte Peters is the COO of MorphoSys AG since . Prior to joining the company, he was an executive at Roche for several years where he led global development and portfolio management.
MorphoSys AG Directors:
1. Marc Cluzel: Chairman of the Board
Marc Cluzel is a medical doctor and the current Chairman of the Board of MorphoSys AG. He has extensive experience in the pharmaceutical industry, having worked at Novartis, Merck, and Pfizer.
2. Markus Enzelberger: Director of Research and Development
Markus Enzelberger serves as the Director of Research and Development at MorphoSys AG. He joined the company in 2004 and has more than 20 years of experience in the biotechnology industry.
3. Sven Ante-Testard: Director
Sven Ante-Testard is a Director of MorphoSys AG. He is currently a partner at the venture-capital firm Medicxi, and has previously worked at GlaxoSmithKline and Goldman Sachs.
Morphosys Ag currently has 511 employees.
|
